NCT05616689View on ClinicalTrials.gov

Bundled Hyperpolypharmacy Deprescribing

NACompletedINTERVENTIONAL
Enrollment

2,471

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

July 29, 2022

Study Completion Date

May 24, 2023

Conditions
Polypharmacy
Interventions
OTHER

Bundled hyperpolypharmacy

Bundled hyperpolypharmacy playbook to be used by pharmacist, with physician approval, in shared decision making with participant,

Trial Locations (1)

94612

Kaiser Permanente Division of Research, Oakland

All Listed Sponsors
lead

Kaiser Permanente

OTHER

NCT05616689 - Bundled Hyperpolypharmacy Deprescribing | Biotech Hunter | Biotech Hunter